Roles of midkine, a heparin-binding growth factor, in the fetal adrenal gland

中期因子(一种肝素结合生长因子)在胎儿肾上腺中的作用

基本信息

  • 批准号:
    17591150
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

The midgestation human fetal adrenal (HFA) is comprised primarily of two zones, the definitive zone (DZ) and the fetal zone (FZ). While the FZ secretes dehydroepiandrosterone sulfate, the function of the DZ is less clear. We have proposed that the DZ phenotype is that of a reservoir of progenitor cells which are small and tightly packed, many of which are mitotically active. In this project, we investigated expression, localization, function, and regulation of midkine (MK), a heparin-binding growth factor with multiple functions, in the HFA. MK mRNA levels in midgestaion HFA's were 4-fold higher than those in adult adrenals. MK immunoreactivity was found abundantly on cell surfaces throughout the HFA. Of interest, MK induced selective proliferation of DZ cells in vitro, providing insights into the mechanism underlying the distinct in vivo differences in mitotic activity between the DZ and FZ. Pharmacological interventions showed that PI 3-kinase, MEK, and src family kinases may be involved in MK-induced proliferation of DZ cells. We also showed that MK down-regulates HSD3B2 mRNA in isolated DZ and FZ cells, indicating that MK may be a component of the mechanisms that underlie in vivo suppression of HSD3B2 expression, the unique adrenal phenotype observed during fetal life. Among the receptors implicated in MK signaling, syndecan-3, a heparan sulfate proteoglycan, was localized only in the DZ. Thus, syndecan-3 could be a candidate for receptor(s) that mediate DZ-selective mitogenic effects of MK. Finally, we demonstrated that ACTH, the primary regulator or HFA development and function, up-regulates MK mRNA in isolated FZ cells, suggesting that MK belongs to a cohort of growth factors regulated by ACTH. Collectively, these results point to key roles of MK in HFA development and function.
妊娠中期人胎儿肾上腺(HFA)主要由两个区带组成,确定区(DZ)和胎儿区(FZ)。虽然FZ分泌硫酸脱氢表雄酮,但DZ的功能尚不清楚。我们提出DZ表型是祖细胞的储库,这些祖细胞小且紧密堆积,其中许多是有丝分裂活性的。在这个项目中,我们研究了中期因子(MK)的表达,定位,功能和调节,肝素结合生长因子具有多种功能,在HFA。中期HFA的MK mRNA水平比成人肾上腺高4倍。MK免疫反应被发现丰富的整个HFA的细胞表面。有趣的是,MK在体外诱导DZ细胞的选择性增殖,为深入了解DZ和FZ之间体内有丝分裂活性明显差异的机制提供了见解。药物干预表明PI 3-激酶、MEK和src家族激酶可能参与MK诱导的DZ细胞增殖。我们还发现,MK下调HSD 3B 2 mRNA在分离的DZ和FZ细胞,表明MK可能是一个组成部分的机制,在体内抑制HSD 3B 2的表达,独特的肾上腺表型在胎儿期观察。在MK信号传导中涉及的受体中,syndecan-3,硫酸乙酰肝素蛋白聚糖,仅位于DZ中。因此,多配体蛋白聚糖-3可能是介导MK的DZ选择性促有丝分裂作用的受体的候选者。最后,我们证明,促肾上腺皮质激素,主要调节或HFA的发展和功能,上调MK mRNA在分离的FZ细胞,这表明MK属于一个队列的生长因子调节促肾上腺皮质激素。总的来说,这些结果指出了MK在HFA发育和功能中的关键作用。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differential Zonal Expression and Adrenocorticotropin Regulation of SPARC, a Matricellular Protein, in the Midgestation Human Fetal Adrenal Gland: Implications for Adrenal Development
SPARC(一种基质细胞蛋白)在妊娠中期人胎儿肾上腺中的差异区带表达和促肾上腺皮质激素调节:对肾上腺发育的影响
Midkine, a Heparin-Binding Growth Factor, Selectively Stimulates Proliferation of Definitive Zone Cells of the Human Fetal Adrenal Gland
Midkine 是一种肝素结合生长因子,选择性刺激人胎儿肾上腺限定区细胞的增殖
ヘパリン結合性成長因子Midkineのヒト胎児副腎における役割(会議録)
肝素结合生长因子 Midkine 在人胎儿肾上腺中的作用(会议记录)
Adrenocorticotropin preferentially up-regulates angiopoietin 2 in the human fetal adrenal gland: Implications for coordinated adrenal organ growth and angiogenesis
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ISHIMOTO Hitoshi其他文献

ISHIMOTO Hitoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ISHIMOTO Hitoshi', 18)}}的其他基金

Studies on pregnancy maintenance mediated by fetal and endocrine factors
胎儿及内分泌因素介导的妊娠维持研究
  • 批准号:
    16K10110
  • 财政年份:
    2016
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Fetoplacental factors involved in feto-maternal communications: who and how
参与母婴沟通的胎儿胎盘因素:谁以及如何
  • 批准号:
    25461655
  • 财政年份:
    2013
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Roles for components of the feto-amniotic unit in maintaining pregnancy
胎儿羊膜单位的组成部分在维持妊娠中的作用
  • 批准号:
    21591423
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on possible roles of midkine, a heparin -binding growth factor, in the human feto -amniotic unit
中期因子(一种肝素结合生长因子)在人胎儿羊膜单位中可能作用的研究
  • 批准号:
    19591288
  • 财政年份:
    2007
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

NPC1调控肾上腺皮质激素分泌影响代谢稳态的机制研究
  • 批准号:
    82370796
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目

相似海外基金

Childhood trauma, hippocampal function, and anhedonia among those at heightened risk for psychosis
精神病高危人群中的童年创伤、海马功能和快感缺失
  • 批准号:
    10825287
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
Generation of functional adrenocortical organoids from mice and humans and their preclinical testing as cell-based therapy for adrenal insufficiency
从小鼠和人类中生成功能性肾上腺皮质类器官及其作为肾上腺功能不全细胞疗法的临床前测试
  • 批准号:
    MR/X021017/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
CAREER: Engineering next-generation adrenal gland organoids
职业:设计下一代肾上腺类器官
  • 批准号:
    2335133
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Continuing Grant
In vivo and ex vivo lessons from somatic adrenal mutations in cell adhesion molecule 1 for physiological and pathological production of aldosterone
细胞粘附分子 1 体细胞肾上腺突变对醛固酮生理和病理产生的体内和离体教训
  • 批准号:
    MR/X018970/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Fellowship
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
  • 批准号:
    10354185
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Decoding the functional pleiotropy of IL-20Rβ ligands in inflammation and tumorigenesis
解码 IL-20Rβ 配体在炎症和肿瘤发生中的功能多效性
  • 批准号:
    10350447
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Probiotic Administration for Adolescent Depression
益生菌治疗青少年抑郁症
  • 批准号:
    10646130
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
  • 批准号:
    10659658
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Stem Cell-Based Models for Elucidating Human Adrenocortical Development and Dysfunction
用于阐明人类肾上腺皮质发育和功能障碍的干细胞模型
  • 批准号:
    10735100
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了